Highlights DIAGNOS Inc.

Equities

ADK

CA2524423068

Market Closed - Toronto S.E. Other stock markets 01:29:47 22/06/2024 am IST			5-day change	1st Jan Change
0.32 ^CAD	+3.23%		-3.03%	-20.99%

05/06	DIAGNOS Raises $0.98 Million in the Second and Final Tranche of a Private Placement of Share Units	MT
05/06	DIAGNOS Inc. announced that it has received CAD 1.295821 million in funding	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

DIAGNOS Raises $0.98 Million in the Second and Final Tranche of a Private Placement of Share Units	06/06	MT
Diagnos Inc. Announces the Launch of Labtician's New Screening Service for Diabetic Retinopathy in Ontario and Renews Its Distribution Agreement	21/05	CI
Diagnos Inc. Announces to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024	06/05	CI
DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	16/04	CI
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units	23/03	MT
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02	CI
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica	11/12	MT
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica	11/12	CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	29/11	CI
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology	05/23/05	CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	24/23/24	CI
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	14/23/14	CI
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS"	17/23/17	CI
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms	28/23/28	MT
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023	14/23/14	CI
Diagnos Gets OK For the Use of Diabetic Retinopathy Screening Technology in Quebec Hospitals	31/23/31	MT
Diagnos Inc Gets the Green Light for the Use of Its Diabetic Retinopathy Screening Technology in Quebec Hospitals	31/23/31	CI
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	25/23/25	CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	30/22/30	CI
Diagnos Enters Retinal Diagnostics Market With New 3D Image Analysis Technology	27/22/27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DIAGNOS Inc.

Equities

ADK

CA2524423068

Highlights

Filters